StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Trading Up 1.5 %
RKDA opened at $6.18 on Wednesday. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $10.31. The stock has a market capitalization of $8.44 million, a PE ratio of -1.44 and a beta of 1.19. The firm has a 50-day moving average price of $4.30 and a two-hundred day moving average price of $3.39.
Arcadia Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 2 Drone Stocks Surging from Increased Media Attention
- What is a Dividend King?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.